In CNBC-TV18's popular show Bull's Eye, Ashish Kapur, Investshoppe shares trading strategy of the day.
Dishman Pharma can move to Rs 135- 140, says Ambareesh Baliga, COO, Way2Wealth.
The supply on the Hepatitis C drug to Vertex by Shasun Chemicals is set to take off earlier than anticipated. "Commercial supplies have already started and this year we are preparing for the launch," says Vimal Kumar, Managing Director of Shasun Chemicals, in an exclusive interview with CNBC-TV18.
Smallcap pharma company Shasun Chemicals has been abuzz lately with conjectures that the firm could see some unlocking of value soon.